Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans

Response to Mechanism of Action of APOL1 in Renal Allograft Survival (and Native CKD) Remains Unclear

(2011) A. M. Reeves-Daniel et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The APOL1 Gene and Allograft Survival after Kidney Transplantation

(2011) A. M. Reeves-Daniel et al.   AMERICAN JOURNAL OF TRANSPLANTATION

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

(2011) R. S. Rosenson et al.   CLINICAL CHEMISTRY

Is Collapsing C1q Nephropathy Another MYH9-Associated Kidney Disease? A Case Report

(2010) Amber M. Reeves-Daniel et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

The Spectrum of MYH9-Associated Nephropathy

(2010) M. A. Bostrom et al.   Clinical Journal of the American Society of Nephrology

Lipotoxicity in Diabetic Nephropathy: The Potential Role of Fatty Acid Oxidation

(2010) M. Murea et al.   Clinical Journal of the American Society of Nephrology

Essential hypertension and risk of nephropathy: a reappraisal

(2010) Mariana Murea et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

(2010) Shay Tzur et al.   HUMAN GENETICS

Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15

(2010) George W. Nelson et al.   HUMAN MOLECULAR GENETICS

The Apolipoprotein L1 (APOL1) Gene and Nondiabetic Nephropathy in African Americans

(2010) B. I. Freedman et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease

(2010) Lawrence J. Appel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans

(2010) G. Genovese et al.   SCIENCE

Polymorphisms in the Nonmuscle Myosin Heavy Chain 9 Gene (MYH9) Are Associated with Albuminuria in Hypertensive African Americans: The HyperGEN Study

(2009) Barry I. Freedman et al.   AMERICAN JOURNAL OF NEPHROLOGY

Apolipoprotein M expression increases the size of nascent preβ HDL formed by ATP binding cassette transporter A1

(2009) Anny Mulya et al.   JOURNAL OF LIPID RESEARCH

Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans

(2009) Barry I. Freedman et al.   KIDNEY INTERNATIONAL

Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD

(2009) B. I. Freedman et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Long-term Effects of Renin-Angiotensin System–Blocking Therapy and a Low Blood Pressure Goal on Progression of Hypertensive Chronic Kidney Disease in African Americans

(2008) Lawrence J. Appel   ARCHIVES OF INTERNAL MEDICINE

Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease

(2008) Keith L. Keene et al.   HUMAN GENETICS

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

(2008) W H Linda Kao et al.   NATURE GENETICS

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

(2008) Jeffrey B Kopp et al.   NATURE GENETICS